Abstract:AbstractIntroductionFollistatin-like protein 1 (FSTL1) is a secreted glycoprotein that has been implicated in arthritis pathogenesis in a mouse model. The aim of this study is to detect FSTL1 expression and to further assess its potential utility as a biomarker of joint damage in osteoarthritis (OA) patients.MethodsFSTL1 expression was detected by real-time PCR, western blot and immunohistochemistry (IHC) in the synovial tissues (STs) and by IHC in the articular cartilage from OA patients and control trauma patients. The serum and synovial fluid (SF) FSTL1 concentrations were measured by ELISA in OA patients and control individuals. Linear regression analyses were used to assess correlations between the serum FSTL1 levels and the clinical characteristics in OA patients.ResultsThe FSTL1 mRNA and protein levels were substantially elevated in the STs from OA patients compared with those from control trauma patients. The FSTL1 expression was strong in the cytoplasm of the synovial and capillary endothelial cells of the STs, but weak in the chondrocytes of the articular cartilage from OA patients. Furthermore, the serum and SF FSTL1 concentrations were significantly higher in OA patients than in respective control subjects. Interestingly, the serum and SF FSTL1 levels were markedly higher in female OA patients than in males. Importantly, bivariate regression analysis revealed that the serum FSTL1 levels in female OA patients had significant correlations with Kellgren and Lawrence (KL) grade, joint space narrowing (JSN) and the Western Ontario McMaster and Universities Osteoarthritis (WOMAC) stiffness subscale, an inverse correlation with height, and marginal correlations with the total WOMAC score and the WOMAC function subscale. Multivariate regression analysis revealed that the serum FSTL1 levels correlated independently with KL grade in female OA patients. Bivariate analysis also revealed that the serum FSTL1 levels correlated significantly with age and disease duration, and they correlated marginally with high sensitivity C-reactive protein (hs-CRP) and KL grade in male OA patients.ConclusionsIncreased FSTL1 expression may be a characteristic of OA patients. FSTL1 is a potential serum biomarker that may reflect the severity of joint damage, and further studies are required to evaluate its potential application for monitoring the course of the disease and the efficacy of therapies in OA patients.

Follistatin-like protein 1: a serum biochemical marker reflecting the severity of joint damage in patients with osteoarthritis

Follistatin‐like Protein 1 (FSTL1) Promotes Chondrocyte Expression of Matrix Metalloproteinase and Inflammatory Factors Via the NF‐κB Pathway

Association of Follistatin-Like 3 Concentrations in Serum and Synovial Fluid with the Radiographic Severity of Knee Osteoarthritis.

Molecular Functions of FSTL1 in the Osteoarthritis

Follistatin‐like protein 1 induction of matrix metalloproteinase 1, 3 and 13 gene expression in rheumatoid arthritis synoviocytes requires MAPK, JAK/STAT3 and NF‐κB pathways

Differential expression of FSTL1 and its correlation with the pathological process of periodontitis

Fibrinogen-Like Protein 1 Is a Novel Biomarker for Predicting Disease Activity and Prognosis of Rheumatoid Arthritis

FSTL1 Promotes Inflammatory Reaction and Cartilage Catabolism Through Interplay with NFκB Signaling Pathways in an in Vitro ONFH Model

Role of follistatin-like 1 levels and functions in calcific aortic stenosis

The secretion of proinflammatory cytokines and chemokines in stimulated fibroblast-like synoviocytes of osteoarthritis

Increased Serum Levels and Chondrocyte Expression of Nesfatin-1 in Patients with Osteoarthritis and Its Relation with BMI, Hscrp, and IL-18

Upregulation of fibroblast growth factor 1 in the synovial membranes of patients with late stage osteoarthritis

YKL-40: a potential biomarker for osteoarthritis.

The Correlation between FSTL1 Expression and Airway Remodeling in Asthmatics.

Abstract 9816: Clinical and Pathophysiological Relevance of Follistatin-Like 1 in Calcific Aortic Valve Disease

Determination of Follistatin-Like Protein 1 Expression in Colorectal Cancer and Its Association with Clinical Outcomes.

Differential Expression of Fibrinogen Alpha and Its Potential Involvement in Osteoarthritis Pathogenesis

Increased Serum Fibroblast Growth Factor-23 (Fgf-23) And Bone Turnover In Patients With Osteoarthritis Of Knee

Targeting FSTL1 for Multiple Fibrotic and Systemic Autoimmune Diseases

Fibroblast growth factor-21 concentration in serum and synovial fluid is associated with radiographic bone loss of knee osteoarthritis.

Follistatin-Like-1 (FSTL1) Is a Fibroblast-Derived Growth Factor That Contributes to Progression of Chronic Kidney Disease